Affiliations

• ¹ Skin Cancer Clinical Trials Center-University of Tuebingen, Tuebingen, Germany.
• ² Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy.
• ³ Department of Medical Oncology and IDIBAPS, Hospital Clinic y Provincial de Barcelona, Barcelona, Spain.
• ⁴ Department of Medical Oncology and Division of Immunology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Ziekenhuis (NKI), Amsterdam; Leiden University Medical Center (LUMC), Leiden, The Netherlands; University Clinic Regensburg, Regensburg, Germany.
• ⁵ Department of Oncology, Melanoma Unit, Istituto Oncologico Veneto, IOV-IRCCS, Padova, Italy.
• ⁶ National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
• ⁷ Department of Dermatology, Skin Cancer Center, USZ-University Hospital Zürich, University of Zürich, Zürich, Switzerland.
• ⁸ Department of Dermatology, Center for DermatoOncology, University Hospital Tuebingen, Tuebingen, Germany.
• ⁹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center and The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, USA.
• ¹⁰ First Department of Medicine, School of Medicine, National and Kapodistrian University of Athens-School of Medicine, Athens, Greece.
• ¹¹ Department of Radiation Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
• ¹² Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, The Netherlands; Oncology Service, Melanoma Clinic, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
• ¹³ Medical Oncology, Cutaneous Malignancies, The Angeles Clinic and Research Institute, A Cedars Sinai Affiliate, Los Angeles, USA.
• ¹⁴ Department of Dermatology, UKSH-Universitätsklinikum Schleswig-Holstein-Campus Kiel, Kiel, Germany.
• ¹⁵ Department of Dermatology, Medical University of Vienna, Vienna, Austria.
• ¹⁶ Université Paris Cite, AP-HP Dermato-oncology and CIC, Cancer Institute APHP, Nord Paris Cité, INSERM U976, Saint Louis Hospital, Paris, France.
• ¹⁷ Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
• ¹⁸ Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department Medical Oncology, Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia.
• ¹⁹ Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
• ²⁰ Mount Vernon Cancer Centre, Northwood, UK.
• ²¹ Department of Oncology, Institut Gustave Roussy and Paris-Saclay University, Villejuif, France.
• ²² Department of Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, France.
• ²³ Department of Dermatology, WTZ-Westdeutsches Tumorzentrum Essen, National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany; University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.
• ²⁴ Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA.
• ²⁵ Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
• ²⁶ Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
• ²⁷ Department of Oncology, Geneva University Hospital, Geneva, Switzerland.
• ²⁸ Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.